Kimberly Clark (KMB) Stock
Global maker of tissue and personal care products. Here's the price, business snapshot, and what's worth knowing about Kimberly Clark in August 2026.
Kimberly‑Clark Corporation (KMB) is a global consumer staples company best known for brands such as Kleenex, Huggies, Kotex and Scott. It manufactures and sells tissue, personal care and professional products, serving both mature and emerging markets. For investors, KMB typically represents a defensive exposure: steady demand for hygiene and household essentials can mean stable revenues and cash flow across economic cycles. Key drivers include brand strength, pricing power, cost control and growth in emerging markets and away‑from‑home channels. Risks include commodity and freight cost inflation (pulp, oil‑based inputs), foreign exchange swings, competitively pressured margins and evolving consumer preferences. Kimberly‑Clark has historically returned capital through dividends and buybacks, but past distributions aren’t guarantees of future pay-outs. This summary is educational only and not personalised advice — values can rise or fall and suitability depends on your individual circumstances.
Why It’s Moving
Kimberly-Clark is moving on a profit beat, but China weakness and softer sales are keeping pressure on the outlook.
- Q2 results showed a profit beat but a sales miss, suggesting Kimberly-Clark is still using productivity gains to offset softer demand rather than relying on stronger volume growth.
- Management cut the 2026 outlook after a disruption in China hurt diaper sales, signaling that regional demand shocks are still pressuring the top line.
- The company said organic sales are running below the pace of its markets, which has investors focusing on whether cost savings can keep propping up earnings through 2026.
Kimberly-Clark is moving on a profit beat, but China weakness and softer sales are keeping pressure on the outlook.
- Q2 results showed a profit beat but a sales miss, suggesting Kimberly-Clark is still using productivity gains to offset softer demand rather than relying on stronger volume growth.
- Management cut the 2026 outlook after a disruption in China hurt diaper sales, signaling that regional demand shocks are still pressuring the top line.
- The company said organic sales are running below the pace of its markets, which has investors focusing on whether cost savings can keep propping up earnings through 2026.
Sixth Month Growth Performance
next-earnings-question
The next expected earnings date for KMB is October 27, 2026. This report should cover third-quarter 2026 results. The date is consistent with the company’s typical late-October earnings pattern, though the exact announcement can still be confirmed by the company closer to release.
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Kimberly-Clark's stock with a target price of $125.67, indicating limited growth potential.
Financial Health
Kimberly-Clark is performing well with solid revenue and cash flow, though margins could be better.
Dividend
Kimberly-Clark's dividend yield of 3.39% provides a moderate return for investors seeking income. If you invested $1000 you would be paid $37.80 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Defensive cash flows
Everyday hygiene products can support steady revenues and dividends; however, performance can vary with input costs and market competition.
Emerging markets growth
Growth opportunities exist outside mature markets as incomes rise, but exposure brings currency and geopolitical risks that may affect results.
Input cost sensitivity
Margins can be squeezed by pulp, packaging and freight inflation; cost management and pricing are key to protecting profitability.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
